Oncotelic Therapeutics (OTLC) Non Operating Interest Expenses (2019 - 2026)
Oncotelic Therapeutics (OTLC) recorded Non Operating Interest Expenses of $318,292 in Q2 2026, up 53.2% from $207,780 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends
On a TTM basis, Oncotelic Therapeutics' Non Operating Interest Expenses came in at $628,772 as of Jun 30, 2026, up 58.1% year-over-year; for FY2025, it was $370,000, up 1.9% from FY2024.
- Annual Non Operating Interest Expenses has a five-year compound annual growth rate of -28.6% (FY2020 to FY2025).
- Across earlier years, Non Operating Interest Expenses came in at $363,000 in FY2024 (-65.3%), $1.04 million in FY2023 (-64.8%), $2.97 million in FY2022 (+48.3%) and $2 million in FY2021 (+0.2%).
- The Q2 2026 figure is the highest quarterly Non Operating Interest Expenses since Q1 2023.
- On a year-over-year basis, Non Operating Interest Expenses rose in three of the last six quarters, with an average decline of 6.9%.
- Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 152.3% in Q2 2022, against a decline of 97.8% in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | - |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | - |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 318,292.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 318,292.00 |
| Dec 31, 2025 | 94,000.00 |
| Sep 30, 2025 | 8,700.00 |
| Jun 30, 2025 | 207,780.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 93,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | -58,709.00 |
| Mar 31, 2024 | 234,709.00 |
| Dec 31, 2023 | 207,686.00 |
| Sep 30, 2023 | 185,424.00 |
| Jun 30, 2023 | 257,396.00 |
| Mar 31, 2023 | 394,278.00 |
| Dec 31, 2022 | 971,882.00 |
| Sep 30, 2022 | 606,824.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 297,464.00 |
| Dec 31, 2021 | 602,564.00 |
| Sep 30, 2021 | 445,363.00 |
| Jun 30, 2021 | 433,979.00 |
API Access
Oncotelic Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();